Capsensixx AG (FRA:CPX) EBIT: €11.0 Mil (TTM As of Dec. 2025)


FRA:CPX Capsensixx AG FRA:CPX
87 GF Score
Price €21.40
GF Value €27.47
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Capsensixx AG EBIT?

Capsensixx AG FRA:CPX 87 EBIT is €11.0 Mil as of Dec. 2025. GuruFocus rates FRA:CPX with a GF Score™ of 87/100 and a GF Value™ of €27.47 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Capsensixx AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €6.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €11.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Capsensixx AG's annualized ROC % for the quarter that ended in Dec. 2025 was 60.48%. Capsensixx AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 211.12%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Capsensixx AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 21.66%.


Capsensixx AG  (FRA:CPX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Capsensixx AG's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=11.694 * ( 1 - 22.53% )/( (13.891 + 16.065)/ 2 )
=9.0593418/14.978
=60.48 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Capsensixx AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=13.14/( ( (5.66 + max(1.676, 0)) + (5.112 + max(-2.199, 0)) )/ 2 )
=13.14/( ( 7.336 + 5.112 )/ 2 )
=13.14/6.224
=211.12 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(15.702 + 0 + 2.899) - (12.841 + 0 + 4.084)
=1.676

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(45.229 + 0 + 0.67999999999999) - (44.384 + 0 + 3.724)
=-2.199

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Capsensixx AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=10.974/50.669
=21.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Capsensixx AG EBIT Related Terms


Capsensixx AG EBIT Historical Data

* Premium members only.

The historical data trend for Capsensixx AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Capsensixx AG EBIT Chart

Capsensixx AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.75 8.71 7.86 8.23 10.97

Capsensixx AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.82 4.16 4.07 4.40 6.57

FRA:CPX vs BLK, BX, KKR: EBIT Comparison

For the Asset Management subindustry, Capsensixx AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Capsensixx AG EV-to-EBIT vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Capsensixx AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Capsensixx AG's EV-to-EBIT falls into.


FRA:CPX
87GF Score
Capsensixx AG FRA:CPX
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Capsensixx AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €11.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €11.0 Mil mean?
Capsensixx AG (FRA:CPX) has a EBIT of €11.0 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Capsensixx AG.
Is Capsensixx AG's EBIT too high?
Capsensixx AG's current EBIT is €11.0 Mil. Overall, Capsensixx AG has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Capsensixx AG's EBIT compare to BLK and BX?
Capsensixx AG's EBIT of €11.0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Asset Management company?
A good EBIT depends on the Asset Management industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Capsensixx AG. Capsensixx AG's current EBIT is €11.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Capsensixx AG stock overvalued right now?
Based on GuruFocus' analysis, Capsensixx AG (FRA:CPX) is currently considered Modestly Undervalued. The stock's GF Value™ is €27.47, compared to a current price of €21.40 — trading 22.1% below its estimated fair value. The current EBIT is €11.0 Mil. Capsensixx AG's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Capsensixx AG (FRA:CPX), the current EBIT is €11.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Capsensixx AG (FRA:CPX) Overvalued in 2026?

Based on GuruFocus' analysis, Capsensixx AG stock appears to be undervalued. The current stock price of €21.40 is trading 22.1% below its estimated GF Value™ of €27.47. GuruFocus considers Capsensixx AG to be Modestly Undervalued.

Key valuation signals for FRA:CPX:

  • EBIT: €11.0 Mil
  • GF Value™: €27.47 vs. price of €21.40 (22.1% below fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the FRA:CPX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Capsensixx AG Business Description

Other Exchanges CPX:Germany
Address Bettinastrasse 57-59, Frankfurt, DEU, D-60325
Capsensixx AG is a provider of financial administration as a service. The company is divided into two segments namely Funds management, Administration and Accounting Segment which includes fund management and fund accounting; and Securitisations which provides Advisory services in the field of financial engineering, securitisation and provision of director and administrative services to corporate clients in Luxembourg.
87GF Score

Get the complete analysis for FRA:CPX

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.40
Price
€27.47
GF Value